1. Home
  2. PSNL vs AZTA Comparison

PSNL vs AZTA Comparison

Compare PSNL & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Personalis Inc.

PSNL

Personalis Inc.

N/A

Current Price

$16.03

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Logo Azenta Inc.

AZTA

Azenta Inc.

N/A

Current Price

$37.99

Market Cap

1.5B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
PSNL
AZTA
Founded
2011
1978
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
2019
1996

Fundamental Metrics

Financial Performance
Metric
PSNL
AZTA
Price
$16.03
$37.99
Analyst Decision
Hold
Buy
Analyst Count
5
6
Target Price
$15.17
★ $37.00
AVG Volume (30 Days)
★ 1.9M
918.1K
Earning Date
11-03-2026
11-20-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 33.58
N/A
EPS
★ N/A
N/A
Revenue
$69,648,000.00
★ $593,821,000.00
Revenue This Year
$21.10
$3.59
Revenue Next Year
$30.66
$4.29
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$4.96
$15.93
52 Week High
$18.89
$46.41

Technical Indicators

Market Signals
Indicator
PSNL
AZTA
Relative Strength Index (RSI) 47.84 58.83
Support Level $15.96 $31.48
Resistance Level $16.39 $41.73
Average True Range (ATR) 0.38 1.97
MACD -0.09 0.20
Stochastic Oscillator 32.11 35.41

Price Performance

Historical Comparison
PSNL
AZTA

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

About AZTA Azenta Inc.

Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.

Share on Social Networks: